These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22264034)

  • 1. Heterocyclic urea derivatives and methods of use thereof (WO2010142978).
    Supuran CT; Scozzafava A
    Expert Opin Ther Pat; 2012 Feb; 22(2):193-7. PubMed ID: 22264034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy.
    Cecchetti V; Fravolini A; Palumbo M; Sissi C; Tabarrini O; Terni P; Xin T
    J Med Chem; 1996 Dec; 39(25):4952-7. PubMed ID: 8960555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2009 Apr; 19(4):529-40. PubMed ID: 19441931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
    Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
    Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
    J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
    Zhang Z; Yu A; Zhou W
    Bioorg Med Chem; 2007 Dec; 15(23):7274-80. PubMed ID: 17826097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit.
    Skugor MM; Stimac V; Palej I; Lugarić D; Paljetak HC; Filić D; Modrić M; Dilović I; Gembarovski D; Mutak S; Eraković Haber V; Holmes DJ; Ivezić-Schoenfeld Z; Alihodzić S
    Bioorg Med Chem; 2010 Sep; 18(17):6547-58. PubMed ID: 20621489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
    Pavlović D; Fajdetić A; Mutak S
    Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials.
    Suresha GP; Suhas R; Kapfo W; Gowda DC
    Eur J Med Chem; 2011 Jun; 46(6):2530-40. PubMed ID: 21481990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones.
    del Valle LJ; Flores L; Vargas M; García-de-la-Guarda R; Quispe RL; Ibañez ZB; Alvarado D; Ramírez P; Ruiz J
    Int J Infect Dis; 2010 Jun; 14(6):e506-10. PubMed ID: 19969497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.